与自相关的基因RB1CC1/FIP200中的有害变异会降低对SARS-CoV-2的免疫力
Lili Hu1,2, Renee M van der Sluis1,2, Kennith Brian Castelino1
1Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Nature communications
|November 27, 2025
概括
编码FIP200蛋白质的RB1CC1中的罕见变异与关键的COVID-19有关. 缺乏FIP200会损害一种新的途径,这种途径可以降解SARS-CoV-2,而不依赖于I型干扰素.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- COVID-19的严重程度各不相同,I型干扰素缺乏症与严重病例有关.
- 编码FIP200的RB1CC1基因变异被研究在患有严重COVID-19的患者中.
研究的目的:
- 调查FIP200在SARS-CoV-2感染和COVID-19病变发生中的作用.
- 确定涉及FIP200的抗病毒机制.
主要方法:
- 对患有严重COVID-19和RB1CC1变种的患者的分析.
- 在气道上皮细胞和细胞系中对FIP200进行基因操纵.
- 评估SARS-CoV-2复制和自流的情况.
- 调查FIP200与NDP52的相互作用及其在病毒降解途径中的作用.
主要成果:
- 两名患有严重COVID-19的非亲属男性患者患有罕见的有害RB1CC1变体.
- 缺乏FIP200的细胞和患有患者变异的细胞显示SARS-CoV-2复制增加和自流失.
- FIP200通过一种新的,非正规的途径调解SARS-CoV-2降解,涉及NDP52和溶酶体降解,独立于正规的自和I型IFN.
结论:
- 一个依赖于FIP200和NDP52的细胞自主抗病毒途径限制了SARS-CoV-2.
- 这一途径独立于正规的自和I型IFN,准病毒在酸性囊泡中降解.
- 这种FIP200依赖途径的损伤可能会导致严重的COVID-19肺炎.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.5K
07:46CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
6.4K
相关概念视频
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Leaky Scanning
5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K
